These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 29615917)

  • 1. Advances in Glioblastoma Multiforme Treatment: New Models for Nanoparticle Therapy.
    Ozdemir-Kaynak E; Qutub AA; Yesil-Celiktas O
    Front Physiol; 2018; 9():170. PubMed ID: 29615917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective treatment of glioblastoma requires crossing the blood-brain barrier and targeting tumors including cancer stem cells: The promise of nanomedicine.
    Kim SS; Harford JB; Pirollo KF; Chang EH
    Biochem Biophys Res Commun; 2015 Dec; 468(3):485-9. PubMed ID: 26116770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasal Drug Delivery of Anticancer Drugs for the Treatment of Glioblastoma: Preclinical and Clinical Trials.
    Bruinsmann FA; Richter Vaz G; de Cristo Soares Alves A; Aguirre T; Raffin Pohlmann A; Stanisçuaski Guterres S; Sonvico F
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31779126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug delivery approaches for the treatment of glioblastoma multiforme.
    Fakhoury M
    Artif Cells Nanomed Biotechnol; 2016 Sep; 44(6):1365-73. PubMed ID: 26046399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
    van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
    Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art.
    Karim R; Palazzo C; Evrard B; Piel G
    J Control Release; 2016 Apr; 227():23-37. PubMed ID: 26892752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New therapeutic approaches for malignant glioma: in search of the Rosetta stone.
    Auffinger B; Thaci B; Nigam P; Rincon E; Cheng Y; Lesniak MS
    F1000 Med Rep; 2012; 4():18. PubMed ID: 22991580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harnessing nanomedicine for therapeutic intervention in glioblastoma.
    Gutkin A; Cohen ZR; Peer D
    Expert Opin Drug Deliv; 2016 Nov; 13(11):1573-1582. PubMed ID: 27292970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasion as target for therapy of glioblastoma multiforme.
    Vehlow A; Cordes N
    Biochim Biophys Acta; 2013 Dec; 1836(2):236-44. PubMed ID: 23891970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Invasive Brain Tumors Using a Chain-like Nanoparticle.
    Peiris PM; Abramowski A; Mcginnity J; Doolittle E; Toy R; Gopalakrishnan R; Shah S; Bauer L; Ghaghada KB; Hoimes C; Brady-Kalnay SM; Basilion JP; Griswold MA; Karathanasis E
    Cancer Res; 2015 Apr; 75(7):1356-65. PubMed ID: 25627979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Potential of Curcumin in the Treatment of Glioblastoma Multiforme.
    Shahcheraghi SH; Zangui M; Lotfi M; Ghayour-Mobarhan M; Ghorbani A; Jaliani HZ; Sadeghnia HR; Sahebkar A
    Curr Pharm Des; 2019; 25(3):333-342. PubMed ID: 30864499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Designing the angiogenic inhibitor for brain tumor via disruption of VEGF and IL17A expression.
    Khan MS; Majid AM; Iqbal MA; Majid AS; Al-Mansoub M; Haque RS
    Eur J Pharm Sci; 2016 Oct; 93():304-18. PubMed ID: 27552907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glioblastoma: Prognostic Factors and Predictive Response to Radio and Chemotherapy.
    Fiorica F; Colella M; Taibi R; Bonetti A; Giuliani J; Perrone MS; Missiroli S; Giorgi C
    Curr Med Chem; 2020; 27(17):2814-2825. PubMed ID: 32003678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Perspectives in Glioblastoma: Nanoparticles-based Approaches.
    Luciano R; Battafarano G; Saracino R; Rossi M; Perrotta A; Manco M; Muraca M; Del Fattore A
    Curr Cancer Drug Targets; 2017; 17(3):203-220. PubMed ID: 27528362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted drug delivery for treatment and imaging of glioblastoma multiforme.
    Stukel JM; Caplan MR
    Expert Opin Drug Deliv; 2009 Jul; 6(7):705-18. PubMed ID: 19538036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breaching barriers in glioblastoma. Part I: Molecular pathways and novel treatment approaches.
    Miranda A; Blanco-Prieto M; Sousa J; Pais A; Vitorino C
    Int J Pharm; 2017 Oct; 531(1):372-388. PubMed ID: 28755993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theranostic Application of Mixed Gold and Superparamagnetic Iron Oxide Nanoparticle Micelles in Glioblastoma Multiforme.
    Sun L; Joh DY; Al-Zaki A; Stangl M; Murty S; Davis JJ; Baumann BC; Alonso-Basanta M; Kaol GD; Tsourkas A; Dorsey JF
    J Biomed Nanotechnol; 2016 Feb; 12(2):347-56. PubMed ID: 27305768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational modeling in glioblastoma: from the prediction of blood-brain barrier permeability to the simulation of tumor behavior.
    Miranda A; Cova T; Sousa J; Vitorino C; Pais A
    Future Med Chem; 2018 Jan; 10(1):121-131. PubMed ID: 29235374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Advances on Glioblastoma Multiforme and Nano-drug Carriers: A Review.
    Liao W; Fan S; Zheng Y; Liao S; Xiong Y; Li Y; Liu J
    Curr Med Chem; 2019; 26(31):5862-5874. PubMed ID: 29768997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Experimenter's Guide to Glioblastoma Invasion Pathways.
    de Gooijer MC; Guillén Navarro M; Bernards R; Wurdinger T; van Tellingen O
    Trends Mol Med; 2018 Sep; 24(9):763-780. PubMed ID: 30072121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.